Liz Tilberis
This month, we celebrate Liz Tilberis, beloved former president of OCRF and editor-in-chief of Harper's Bazaar.
News
News from AACR: Irregular Menses Linked to High Risk of Ova...
News from AACR: Irregular Menses Linked to High Risk of Ovarian Cancer
(April 15, 2014) Prolonged (>35 days), infrequent, or anovulatory menstrual cycles was associated with as much as a two-fold increase in ovarian cancer and more than a three-fold increase in the risk of fatal ovarian cancer, according to a 50-year, prospective follow-up in 14,403 women. The findings were presented at the American Association for Cancer … Continued
Physical Activity Associated with Lower Risk of Ovarian Can...
Physical Activity Associated with Lower Risk of Ovarian Cancer Mortality
(April 8, 2014) A team of researchers have found that vigorous physical activity prior to ovarian cancer diagnosis was associated with a lower risk of ovarian cancer mortality. The findings were published in Gynecologic Oncology. There is limited knowledge of the association of modifiable lifestyle factors, such as physical activity and obesity on mortality among … Continued
Rachel Zoe and Molly Sims to host Ovarian Cancer Research F...
Rachel Zoe and Molly Sims to host Ovarian Cancer Research Fund’s Inaugural Super Saturday LA
Designer Charity Sale expands to the West Coast in celebration of OCRF’S 20th Anniversary; Offers Day-Long Luxury Experiences for the Whole Family Los Angeles, CA (April 7, 2014) – Rachel Zoe and Molly Sims with their husbands Rodger Berman and Scott Stuber will host Ovarian Cancer Research Fund’s 1st Annual Super Saturday LA. The event, … Continued
OCRF Research Identifies Fusion Gene Common in Ovarian Cancer
OCRF Research Identifies Fusion Gene Common in Ovarian Cancer
(April 7, 2014) A group of OCRF-funded researchers at Baylor College of Medicine have found a “fusion gene” that is present in 20% of high grade serous ovarian cancer patients. The finding, which was published in PLOS Genetics, was supported in part by OCRF grants to Martin Matzuk, MD, PhD, Shannon Hawkins, MD, PhD, and … Continued
108 Members of the House of Representative Support Ovarian ...
108 Members of the House of Representative Support Ovarian Cancer Research Funding
Each spring, Congress takes up the task of allocating money to federal programs. And each spring, the Ovarian Cancer National Alliance works to ensure that ovarian cancer research funding remains a top priority. This year was no exception. On Wednesday, 108 Members of the House of Representatives sent a letter to the House Appropriations Committee … Continued
Discoverer of BRCA genes said “being ignored” h...
Discoverer of BRCA genes said “being ignored” helped her do her research
Last week marked the 20th year anniversary of the discovery of the BRCA1 gene by Mary-Claire King, Ph.D., an American geneticist. Dr. King, who was interviewed last week by NPR, talked about how being ignored by her male colleagues actually made it easier for her to do her work. At the time of her discovery, … Continued
Updates from the 2014 Society for Gynecologic Oncology Annu...
Updates from the 2014 Society for Gynecologic Oncology Annual Meeting
Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology (SGO) meeting. Some of the biggest news for the ovarian cancer community is summarized below, including SGO’s recommendations regarding genetic testing of ovarian cancer patients … Continued
2015 OCRF Requests for Proposals Now Available
2015 OCRF Requests for Proposals Now Available
(April 1, 2014) Ovarian Cancer Research Fund is now accepting Letters of Intent for its three research grant programs. Letters of Intent must be submitted by May 6, 2014 at 5:00pm ET.
Causative mutation found for rare form of ovarian cancer af...
Causative mutation found for rare form of ovarian cancer affecting young women
A rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (or SCCOHT) can affect women and girls as young as 14 months old. This week, researchers at the Translational Genomics Research Institute (TGen) in Arizona, announced that they had found a mutation in a gene called SMARCA4 responsible for this … Continued
Vynfinit gains European approval for treatment of platinum-...
Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in the treatment of some platinum resistant ovarian cancers. Vynfinit, developed by Endocyte, targets ovarian cancer cells that have abnormally high levels of the folate receptor. … Continued
Gene Mutation Causes Rare Ovarian Cancer
Gene Mutation Causes Rare Ovarian Cancer
(March 25, 2014) In what is being hailed as a major discovery, findings published this week indicate that researchers have discovered a gene mutation that causes Small Cell Carcinoma of the Ovary, Hypercalcemic type. OCRF Scientific Advisory Committee member, and former grantee, Douglas A. Levine, MD, is senior author of one of three papers on … Continued